NEOGEN

July 26, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Kala Ghoda, Fort Bandra Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Sub.: Earnings Presentation on the Unaudited Financial Results of the Company for the quarter ended June 30, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2026. The Earnings Presentation is also being uploaded on the Company’s website at https://neogenchem.com/financial-performance/. Kindly take the same on your record. Thanking you, For Neogen Chemicals Limited ______________________________ Unnati Kanani Company Secretary and Compliance Officer Mem. No.: A35131 Encl.: As above Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 ‘Capitalising on Opportunities Rising in Strength’ Q1 FY27 Earnings Presentation July 2026 Safe Harbor Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Neogen Chemicals Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances. 2 Table of Contents 01 02 03 01 02 03 Q1 FY27 Financial Introduction to Industry Overview: Performance & Neogen Chemicals Lithium-Ion Batteries Expansion Initiatives 04 05 06 04 05 06 Way Forward Sustainability & Contact Us CSR Initiatives Q1 FY27 Financial Performance & Expansion Initiatives Performance Highlights – Q1 FY27 Q1 FY27 Revenue break-up** INR in crore Standalone Consolidated 70% Revenues 37% 252 34% 250 30% Domestic *Exports Gross Profit 31 % 109 37% 117 *Including deemed exports EBITDA 39% 48 53% 48 57 23% 22 PAT 37% 19 67% 17 194 77% 165 Q1 FY26 Q1 FY27 Organic Inorganic **Consolidated figures Note: Growth for Q1 FY27 is compared to Q1 FY26. 5 Financial Summary – Q1 FY27 Standalone Consolidated Standalone Consolidated Standalone Consolidated REVENUE EBITDA PAT INR in crore INR in crore INR in crore 17 252 250 48 48 19 185 187 35 32 14 10 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 ● Strong growth despite the temporary Dahej ● Robust EBITDA despite ongoing global ● PAT trajectory reflected strong underlying plant shut down. Managed by efficient headwinds; cost pass-throughs initiated for operating trends, partly moderated by higher management of toll manufacturing sites RM and input costs (freight, packaging, finance costs (up 64% Y-o-Y) utilities, etc.) to protect operating margins ● Revenue expansion anchored by higher ● Increased interest burden driven by: volumes for key product lines ● Performance was bolstered by favorable o Higher debt drawdown to fund product mix, achieving highest-ever quarterly ● Organolithium Portfolio delivered robust ongoing CAPEX revenues in both Organolithium and Battery gains driven by enhanced plant throughput o Increased working capital intensity Chemicals, alongside strong volume growth ● Neogen Ionics (NIL): Q1 FY27 revenue in Inorganic Chemicals. This was achieved driven by geopolitical supply chain reached INR 19 crore (vs. INR 5 crore in Q1 despite headwinds from higher costs, inflation FY26) including temporary expenses related to the o Delay in insurance receipts Dahej plant rebuild, toll manufacturing, expansion overheads at NIL, and geopolitical freight spikes 66 Financial Table – Profit & Loss Statement (Standalone) Particulars (INR In crore) Q1 FY27 Q1 FY26 Growth (%) Revenue 252.3 184.6 37% Expenditure 204.1 149.9 36% EBITDA 48.2 34.7 39% EBITDA Margins 19.1% 18.8% +30 bps Depreciation 6.8 4.9 40% Other Income 7.9 3.3 139% EBIT (inc. Other Income) 49.2 33.1 49% Interest 23.1 14.0 65% Profit Before Tax 26.1 19.1 37% PBT Margins 10.4% 10.3% +10 bps Exceptional Items 0.0 0.0 NA Profit Before Tax (inc. exceptional items) 26.1 19.1 37% Tax Expense 6.7 4.9 38% Profit After Tax 19.4 14.2 37% PAT Margins 7.7% 7.7% - Earnings Per Share (INR) *7.15 *5.40 32% * Not annualized 7 Financial Table – Profit & Loss Statement (Consolidated) Particulars (INR In crore) Q1 FY27 Q1 FY26 Growth (%) Revenue 250.3 186.7 34% Expenditure 202.1 155.2 30% EBITDA 48.2 31.5 53% EBITDA Margins 19.3% 16.9% +260 bps Depreciation 8.2 5.8 42% Other Income 3.9 1.2 227% EBIT (inc. Other Income) 43.9 26.9 63% Interest 20.8 12.7 64% Profit Before Tax (including share of profit) 23.3 14.3 63% PBT Margins 9.3% 7.7% +160 bps Exceptional Items 0.0 0.0 NA Profit Before Tax (inc. exceptional items) 23.3 14.3 63% Tax Expense 6.2 4.0 53% Profit After Tax 17.1 10.3 67% PAT Margins 6.8% 5.5% +130 bps Earnings Per Share (INR) *6.29 *3.89 62% * Not annualized 8 Key Updates – Q1 FY27 (Neogen Chemicals) Update on Dahej Fire Incident • Cumulative recoveries stand at INR 164 crore to date, comprising INR 155 crore in on-account insurance claims (including a recent tranche of INR 15 crore in July 2026) and INR 9 crore from salvage realization and has incurred further incidental charges of INR 1 crore which is also claimed as per insurance policy upto June 30, 2026. o Net claim receivable as on date stands at INR 186 crore on consolidated basis • Reconstruction of the Dahej plant is complete, with trial runs underway; commercial production to begin soon Board Approval for Fund Raise • The Board has approved raising up to INR 600 Crore (in INR or foreign currency) through issue of eligible securities, by way of a Qualified Institutional Placement (QIP), subject to necessary shareholder and statutory approval 9 Update on various expansion initiatives Neogen Ionics Proposed Manufacturing Setup Manufacturing locations Land Area Year Planned Capacities Electrolyte Lithium Electrolyte Salts & Additives FY25 2,000 MT 400 MT Dahej SEZ 6,455 m2 FY26 - 1,100 MT FY27 - 1,000 MT Pakhajan, Dahej PCPIR (New site) 264,285 m2 FY27 30,000 MT 3,000 MT Total 270,740 m2 32,000 MT 5,500 MT Battery Chemicals Business Details of expansion projects announced Current project updates Capacity of 1,500 MTPA for manufacturing ● 200 MTPA commissioned; first approval material shipped to the customers Lithium Electrolyte Salts and additives ● For remaining 1,300 MTPA, trial production ongoing Lithium Electrolyte Salts Plant for manufacturing 2,000 MT of Electrolyte Electrolytes ● 2,000 MT fully commissioned in FY25 at Dahej facility 10 New Capacity of 1,000 MTPA for manufacturing ● 1,000 MT to be commissioned by H2 FY27 Lithium Electrolyte Salts and Additives ● 500 MT additional intermediate to be commissioned in H2 FY27 Update on Battery Chemicals (Neogen Ionics) Execution Roadmap & CAPEX Project Updates • Total estimated project cost for Neogen Ionics’ Dahej Phase 1 and • Project completion timelines remain on schedule for Electrolytes (H1 FY27) Pakhajan Phase 2 Battery Materials projects stands at INR 1,795 crore and Electrolyte Salts (H2 FY27) (INR 218 crore incurred in Q1 FY27; cumulative INR 1,298 crore to date) • Electrolyte: Mechanical assembly complete and trial runs initiated; facility o Dahej Phase 1 project cost stands at INR 428 crore with target validation and product approvals by leading domestic battery manufacturers completion by February 2027, while Pakhajan Phase 2 is underway, in line with growing ACC ecosystem demand budgeted at INR 1,367 crore with completion expected by March • Strong engagement with both domestic and global cell manufacturers for 2027 electrolyte salt supplies o Project scope and specifications reflect design optimizations • Lithium Electrolyte Salts: Provisional approvals secured from 4 major following the transition to advanced Japanese technology, international customers and completed final site audits for 3 US-based alongside enhanced localization of critical sub-components to electrolyte manufacturers; commercial supplies to begin post-final reduce import dependence and boost long-term operational approvals of plant trials reliability o Morita’s $20 million equity contribution toward the JV remains o Both projects continue to receive strong strategic backing through committed as planned promoter equity infusion and planned JV partner funding support. Pakhajan Facility 1111 Management Commentary Dr. Harin Kanani Managing Director Commenting on the performance, Dr. Harin Kanani, Managing Director, at Neogen Chemicals said: “We have delivered robust performance in Q1 FY27, marking a strong start to the new financial year. This performance was driven by volume gains across our core business lines led by sustained customer off-take and the highest revenue ever recorded in our Organolithium portfolio, alongside a stellar start at Neogen Ionics, which generated over 50% of its entire prior-year revenue in Q1 FY27 alone. Despite global supply chain pressures, elevated inputs costs and plant transition activities at Dahej, our underlying business fundamentals remain sound. As our replacement Dahej plant scales up, we are well-positioned to leverage our expanded capacities and drive sustainable growth. Our battery materials project remains firmly on track with projected timelines. Backed by successful customer validations, international site audits, and key client approvals, Neogen Ionics stands at a pivotal junction, uniquely positioned as a preferred partner for domestic and global cell manufacturers. This position is further strengthened by favorable Government support and policy actions, alongside production ramp-up by PLI ACC battery manufacturers and the allocation of the 10 GWh re-bidding tranche. More importantly, the Government’s intention to incentivize battery component manufacturers through a proposed PLI scheme will accelerate supply chain localization. Through the localization of advanced battery chemistry, we will actively support India’s mission to build a self-reliant domestic ecosystem for EV and energy storage applications, while servicing global non-FEOC demand. Moving forward, FY27 will be a defining year of execution for Neogen Chemicals, as we commission and scale up our battery materials project to emerge as a critical player in the battery chemicals ecosystem. Concurrently, with our replacement Dahej facility nearing operational readiness, our core base business is set to resume its normalized growth trajectory this year. Reaffirming our previously shared guidance, we remain focused on executing our strategic CAPEX roadmap and unlocking operating leverage to deliver sustainable, long-term growth and value creation for shareholders.” 12 Historical Financial Trends (Consolidated) Net Revenue from Operations* (INR crore) EBITDA (INR crore) Margin (%) CAGR: 21% 17.5% 15.9% 160 19.1% 16.3% 15.9% 136 137 25.0% 17.8% 10 90 00 0 686 691 778 862 1 1 2 4 0 0 112 110 20.0% 800 700 487 100 65 87 15.0% 600 80 500 336 400 60 10.0% 300 40 200 5.0% 100 20 0 0 0.0% FY21 FY22 FY23 FY24 FY25 FY26 FY21 FY22 FY23 FY24 FY25 FY26 PAT (INR crore) Margin (%) Networth (INR crore) Net Debt (INR crore) 1295 1400 9.3% 9.2% 1200 7.3% 60 50 5.2% 4.5% 9 1 . 0 0 . % 0% 1000 760 789 816 4 5 0 0 31 45 36 35 3 2 .3 9 % 6 7 8 . . . 0 0 0 % % % 6 8 0 0 0 0 439 483 530 30 5.0% 378 4.0% 400 265 20 3.0% 183215 99 10 2.0% 200 1.0% 0 0.0% 0 FY21 FY22 FY23 FY24 FY25* FY26 FY21 FY22 FY23 FY24 FY25 FY26 * Includes Exceptional Item of INR 14.08 crore on account of damage to certain property, plant & equipment, inventory and estimated cost of incidental charges due to fire incident at the Dahej plant 13 Seasonal Variance Factors Neogen’s business has Demand for Demand from the Consequently, some seasonal drivers, Lithium-based agrochemicals segment investors are urged to due to which the chemicals tends to be is linked to the crop compare financial Company tends to strong in Q4 as demand cycle and is stronger performance of each deliver stronger from the HVAC during H2 quarter only with that of financial performance segment, a key usage the corresponding in the second half of area, is linked to capital quarter previous year to the financial year expenditure that enjoys evaluate business (October to March) due 100% depreciation progress on a to strong demand from benefits for like-to-like basis Europe which typically air-conditioning/ scales up in October- cooling machines November and further accelerates from January after the holiday season​ 14 Neogen Chemicals – At a Glance ISO 9001:2015, ISO 14001:2015, 4 Manufacturing Sites + 258 934* ISO 20400:2017 & ISO 45001:2018 816* 21%* 2 R&D Facilities and others* 16 Products developed Infrastructure Employees (of Manufacturing units certified on Net worth: 5-year Revenue by in-house R&D which 13% of Quality & SHE management systems March 31, 2026 CAGR workforce is in (INR crore) R&D team) Leading Largest Importer Customers Growing Promoters are manufacturer of of Lithium across multiple contribution from technocrats with Bromine and Carbonate for industries Custom substantial Lithium-based last 3 decades – including Synthesis and domain specialty Strong Pharma, Contract expertise; chemicals, Relationship with Engineering, Manufacturing cumulative operating since Global Leading Battery experience of 1991 – Over 30 Lithium Miners & Chemicals and more than six Years of Strong Processors Agrochem decades History * Consolidated Evolution of Neogen Chemicals 1970’s to 1991 Pre-Neogen 1991 to 2016 Site I 2016 to 2019 Site I & II 2020 to 2025 Multiple Sites ● Mr. HT Kanani is a Chemical ● ‘Neogen Chemicals’ ● Acquired Solaris ChemTech ● Doubled Inorganic Chemicals Engineer from IIT Bombay. His commenced business Industries’ Bromine derivatives capacity from 1,200 MT to 2,400 association with Bromine operations in 1991, at Mahape, plant at Vadodara in 2016 via MT chemistry started in the early Navi Mumbai manufacturing a slump sale 1970s​ few Bromine Compounds and ● Raised ~INR 225 crore through o Included ~157,827 sq. Lithium Compounds preferential allotment in Dec 2021 ● Set up one of India’s first meters of land, plant and Bromine plants using indigenous machinery, ~50 trained ● Signed agreement with MUIS, ● Set up dedicated R&D and Japan to acquire manufacturing technology at Gujarat manpower and several hired first PhD scientist in 2001 technology license for electrolytes technologies developed in- o Plant was later destroyed in in India house 1970s by flooding in Morbi ● Capacity expansions at Mahape plant took place in 2000, 2007 ● Acquired 100% stake in BuLi due to dam collapse o Mr. Kanani worked as a and 2012 ● Turnover more than tripled to Chem to offer organolithium Rs. 300 crore in FY19 products consultant for setting up Bromine and other ● Dr. Harin (now MD) re-joined ● Raised ~ INR 253 crore through manufacturing units till 1984 Neogen Chemicals in 2008 after preferential allotment in Nov 2023 to recover these losses pursuing his PhD in Chemical Engineering from University of ● Neogen Ionics acquired 65 acres ● In 1985, started manufacturing Maryland, USA of land in Pakhajan, Dahej Bromine derivatives from a 600 PCPIR, for dedicated Battery sq. ft. plant to start making n- ● Reached Rs. 100 crore by FY16 Materials project propyl bromide and lithium from Mahape plant ● Neogen Ionics commences sales bromide of Lithium Salts and Electrolytes from Dahej SEZ plant 17 Milestones Leading manufacturer of Bromine and Lithium-based specialty chemicals since 1989 • Started • Raised INR 132 • Increased Organic • Approved Merger of • Promoter infused manufacturing crore through initial Chemicals reactor Buli Chemicals with INR 161 crore speciality bromine public offering (IPO) capacity to 407,000 Neogen Chemicals through compounds and Offer for sale liters preferential • NIL begins sales of allotment • Increased reactor • Raised ~ INR 225 Lithium Salts & capacity at Mahape crore through Electrolytes from to 45,000 litres preference share Dahej SEZ plant allotment • Acquired land in Dahej SEZ 2001-2015 2019 2021 2024 2026 1989-2000 2016 2020 2023 2025 • Incorporation as a • Achieved turnover of • Increased the • Signed licensing • Expanded Patancheru plant private limited ₹100 crore capacity of Inorganic agreement with MUIS, capacity (BuLi Chem) from 120 company Chemicals to 2,400 Japan MT active to 300 MT active • Acquired MT through • Started operations manufacturing • Acquired 100% stake in • Incorporated 100% subsidiary of Greenfield with Lithium salts operations of Solaris BuLi Chem NIL namely, ‘Neogen Morita New expansion at Dahej, and organic bromide Chemtech Limited at Materials Limited Gujarat • Raised ~INR 253 crore at Mahape Karakhadi, Gujarat through preferential • Raised INR 200 crore via NCDs (Vadodara) • Increase in capacity allotment • Execution of JV: Neogen Ionics • Conversion to public • Neogen Ionics (NIL) (NIL) and Morita Investment limited company acquired 65 acres of land (MIL) in Pakhajan, Dahej PCPIR 18 Business Overview Organic Chemicals End User Industries Bromine Organolithium Advanced Custom Synthesis & Compounds N Butyl Lithium and Intermediates Contract Organic compounds other organolithium Combining Manufacturing containing bromine, products using bromination with Products developed chlorine, fluorine, highly reactive other chemistries to for specific customers. iodine-based, Lithium metal; key create forward- Process know-how combinations thereof reagents for integrated value- and technical and others including Lithiation reaction added products specifications are Pharmaceuticals Agro Flavors & Semi Electronic grignard reagents developed in-house chemicals Fragrances conductors Chemicals Inorganic Chemicals End User Industries The portfolio includes specialty, inorganic lithium-based chemical products which find applications across multiple industries Eco-friendly VAM for Pharmaceuticals Specialty Battery cooling air/ water/ Polymers Chemicals process equipment Select Clientele 19 Unique value-proposition Experienced Board of Directors Specialised Business State-of-the-art Model with High Entry Barriers Manufacturing Facilities Established Excellent R&D Relationship with Suppliers Capabilities Enduring Customer Innovative Relationships Product Portfolio 20 Experienced Leadership Team ● Holds a bachelor’s degree in commerce with Honours Mr. Shyamsunder from the University of Delhi Dr. Harin Kanani Mr. TCN Sai Krishnan Mr. Gopikrishnan Sarathy Upadhyay ● Rich experience of over 35 years in the Specialty Chemical Industry Managing Director Whole time Director Executive Director Chief Financial Officer ● N se o v n e - r E a x l e le c a u d ti i v n e g / S I p n e d c e i p a e lt n y d C e h n e t m D ic ir a e l c c to o r m p o a n n ie th s e Board of Neogen Chemicals ● Holds a master’s degree ● Holds MBA degree with ● Associate member of Limited (NCL & NIL) the Institute of Chartered in science from Vikram Chemical engineering ● A well-known personality in the Agrochemical and Accountants of India, Mr. Anurag Surana, specialty chemical industry in India, Europe and Japan ● Holds a bachelor’s degree in University, Ujjain ● 33 years of experience and Diploma in IFRS ● 41 years of work in Manufacturing, Non-Executive ● To help elevate growth through sound corporate chemical engineering from IIT, from ACCA UK experience in the field of Projects, Procurement Chairman, NCL governance and translating strategy into reality via a Bombay and a Master’s chemicals & Supply Chain with ● Over 25 years of diverse culture of agile execution and accountability degree and a doctorate in experience in the field of chemical engineering from the ● Oversees maintenance, specialty chemicals, Finance & Accounts, University of Maryland projects, logistics, petrochemicals, paints, Strategic Planning and administration and inks & FMCG industries ● Served as a research fellow at Budgeting, M&A and ● An eminent Chartered Accountant with over 45 years’ the University of Maryland, engineering store in the Investor relations among experience where he has published 4 first company others ● Successfully managed the growth of M/s Akkad Mehta & author manuscripts in the field Co. LLP of chemical engineering ● Carved his niche as a thorough professional by ● Joined NCL in 2008 and is on consistently delivering solutions out of the box that are the Board since 2017 technically sound, innovative and implementable for the ● Has previously worked with Mr. Kirit Chauhan Mr. B P Pant Mr. Hideji Hosoda Mr. Sanjay Mehta clients companies such as Asian Non-Executive ● Brings in the best Governance practices and also provide Paints India and as a senior Chairman, NIL guidance on compliance to the NIL Leadership Team research scientist at Pioneer President – HR & Admin President – New Prod. President – Neogen Japan Hi-Bred International Inc. (DuPont Subsidiary) in the ● Holds a degree in ● Holds M Sc degree in ● Veteran with more than 4 decades of experience United States M.L.W., PGDHRM with a Organic Chemistry from and a well-known person focus on Labour Laws the Department of in the agrochemical ● Holds a bachelor’s degree in chemical engineering from from South Gujarat Chemistry at Pune industry in Japan IIT, Bombay University University ● Established 1st Bromine Plant of India with Indigenous ● Extensive experience in ● Over 2 decades of ● Plays a very active role in Advising Neogen on all technology human resources and extensive work strategic initiatives in the administration experience in the ● Guided Neogen as Chairman and Managing Director from Battery Chemical and chemical industry, with 1989 to 2025 - over 35 years, growing 750x, exporting to other Specialty Chemical focus on business 28 countries from multiple locations. business in Japan development Dr. Haridas Kanani, ● Appointed as ‘Chairman Emeritus’ after completing 80 Chairman Emeritus years of age – to continue providing valuable guidance and mentorship to Neogen Chemicals 21 Strong Manufacturing Infrastructure – Neogen Chemicals Strong Manufacturing Infrastructure Factory Land Area Land Utilisation Capacity Certifications of Manufacturing Facilities Organic Chemicals Inorganic Chemicals (Reactor capacity) (Tonnage) ISO 9001:2015, ISO 26000:2010, ISO 31000:2018, Mahape (Since 1991) 4,045 m2 100% 69 m3 9 m3 ISO 37001:2016 from Bureau Veritas ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, Vadodara (Since 2017) 161,874 m2 20% 111 m3 - ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 from Bureau Veritas ISO 9001:2015, ISO 14001:2015, ISO 45001: 2018, ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 Dahej (Since 2020)* 43,374 m2 - Earlier 258 m3 Earlier 30 m3 ISO 20400:2017 from Bureau Veritas and also, GMP (Good Manufacturing Practices) certified by SGS Total 209,293 m2 438 m3 39 m3 ISO 9001:2015, ISO 14001: 2015, ISO 45001: 2018 Patancheru (May 2023) 16,187 m2 50% 300 MTA - from Bureau Veritas *Following the fire incident at Dahej plant in March 2025, the current capacity is unavailable. However, a replacement plant of the same capacity is currently under construction, expected to be operational by Q2 FY27 Quality Control and Quality Assurance World-class operational practices ● Dedicated QC and QA team in place monitoring the entire manufacturing process at all ● Zero Liquid Discharge, significantly reducing water usage stages right from initial testing stage to the final product ● Focus on compliance with stringent quality and EHS norms ● Implemented current good manufacturing practice (cGMP) prescribed by the US FDA as applicable for intermediates 22 Driving Innovation Through R&D 1 2 3 4 5 1 Established two 125-member Focus on R&D to MD actively Post commissioning R&D units dedicated R&D drive sustained involved and of dedicated R&D team, including growth; to spend significant units in 2001, the 9 Ph. D. continue to deploy time overseeing product portfolio resources the functioning of has grown from 20 R&D divisions products in 2001 to 258 products in Q1 FY27 23 Key Export Geographies China Europe Korea Export sales of 30% USA Japan in Q1FY27 Middle East 24 Strong Opportunities in Lithium Battery Sector – India ● Government’s PLI Scheme for ACC Batteries: Backed by an outlay of ₹18,100 crore to build 50 GWh of Advanced Chemistry Cell manufacturing capacity, the scheme mandates scaling domestic value addition to 60% within 5 years to drive a localized EV ecosystem ● Direct investment of around INR 45,000 crore in ACC Battery storage manufacturing projects ● Rebidding: Govt. has invited global bids to establish 10 GWh of giga-scale Advanced Chemistry Cell (ACC) battery manufacturing capacity with a maximum outlay of INR 3,620 crore under the PLI scheme ● Proposed PLI for battery components will incentivize domestic cell manufacturers to localize their raw material sourcing, accelerating commercial off-take for Neogen’s electrolyte and lithium salt capacities Battery Demand by 2032 • Total 63.4 GWh under various stages of development 250 236 GWh • Out of the total 63.4 GWh, 26.7 GWh is scheduled for commissioning in 200 2026 ) H W • Overall, 13+ players announced G 150 ( manufacturing capacities d n a 92 GWh • 220+ GWh of total capacities m 100 e announced D y e 50 33 GWh • 3.53 GWh of total installed capacities t t a B 0 2025 2027 2032 Source: Report by Ministry of Heavy Industries dated March 2026, titled ‘Aggregation of Multi-Sectoral Long-Term Battery Storage Capacity Demand And Long-Term Action Plan 26 Strong Opportunities in Lithium Battery Sector - Global Demand Estimates for the Global Market (By 2030) Estimated Battery requirement (GWh) Estimated Electrolyte demand (KT) Estimated Lithium Salt demand (KT) 3,500 3,500 400 3,000 3,000 350 2,500 1,500 2,500 1,125 300 141 250 2,000 2,000 200 366 1,500 3,000 1,500 2,925 150 225 1,000 1,500 1,000 1,800 100 500 500 50 0 0 0 China & Non-China Total China & Non-China Total China & Non-China Total China Non-China China Non-China China Non-China Demand for non-Chinese Manufacturing of Lithium-Ion battery cells is To secure the US Govt. Tax credit (45X), U.S. LiB cell producers Electrolyte and Lithium Salts is ramping up in India, with major battery must adhere to Foreign Entity of Concern (FEOC) guidelines. This projected to increase substantially producers actively advancing project necessitates a shift to non-FEOC suppliers by 2027. Consequently, by 2030 execution, driving demand for Electrolyte and most international customers are proactively accelerating their captive consumption of Lithium Salts supplier transition to non-FEOC sources in different phases during 2026 to mitigate compliance risk and ensure continued eligibility for the credit with full transition expected by 2027 27 Way Forward Expand capabilities in adjacent high-end complex chemistries Enhance focus on CSM & Deep inroads in the Advanced Intermediates Battery Materials through portfolio expansion segment Augment the Leverage strong R&D capacities of Organic expertise to introduce and Inorganic Chemicals innovative offerings 28 Sustainability: Driving Value through ESG Excellence Strategic ESG Integration for Sustainable Growth Clean Energy Robust Ethical Strengthening Focus Oversight Foundation Corporate Governance The upcoming Dahej ESG risks are formally The Board has approved Aligned with best Greenfield project is integrated into the comprehensive policies corporate governance strategically focused on mandate of the Risk covering all 9 principles of practices, the Company manufacturing Lithium-ion Management Committee, the National Guidelines separated the positions of Battery Materials and ensuring sustainability on Responsible Business Chairman and Managing Specialty Chemicals, considerations inform Conduct (NGRBC), Director. directly supporting the core business strategy extending to our value global clean energy chain partners. Zero Mr. Anurag Surana, a transition complaints reported for non-promoter family corruption, bribery, or member, was designated human rights violations in as the Non-Executive the reporting period Chairman 29 CSR Approach: Focusing On The Greater Good Shaping an Inclusive and Sustainable Future INR 56.01 Lakh Education INR 11.26 Lakh INR 34.10 Lakh CSR Healthcare Focus Water Conservation Areas & Natural Resource (FY26) Management INR 14.97 Lakh INR 20.95 Lakh Environment Rural Development and Women Empowerment Securing the EcoVadis Silver Medal for 2026 highlights Neogen's continued progress in ESG and its firm commitment to sustainability and responsible business practices. 3300 Contact Us About Neogen Chemicals Limited Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the leading manufacturers of Bromine-based and Lithium-based specialty chemicals. Its specialty chemicals product offerings comprise of Organic as well as Inorganic chemicals. Its products are used in pharmaceutical and agrochemical intermediates, engineering fluids, electronic chemicals, polymer additives, water treatment, construction chemicals, and aroma chemicals, flavours and fragrances, specialty polymers, Chemicals and Vapour Absorption Chillers – original-equipment manufacturers and new upcoming usage in lithium-ion battery materials for energy storage and Electric Vehicles (EV) application. Over the years, Neogen has expanded its range of products and at present, manufactures an extensive range of specialty chemicals which find application across various industries in India and the world. It has a product portfolio of over 258 products. In addition to manufacturing specialty chemicals, Neogen also undertakes custom synthesis and contract manufacturing where the product is developed and customised primarily for a specific customer, but process know-how and technical specifications are developed in-house. The Company has announced plans to utilise its three decades of experience in Lithium Chemistry to manufacture Lithium-Ion battery materials with an initial investment plan of manufacturing electrolytes and Lithium electrolyte salts. The Company operates out of its four manufacturing facilities located in Mahape, Navi Mumbai in Maharashtra, Dahej SEZ, Bharuch and Karakhadi, Vadodara in Gujarat and in January 2025 Buli Chemicals India Private Limited- the wholly owned subsidiary was merged with the Company, which has its manufacturing unit located in Patancheru, Hyderabad. In December 2023, Neogen Ionics, a wholly owned subsidiary of Neogen Chemicals Limited acquired 65 acres of land in Pakhajan, Dahej PCPIR, Gujarat dedicated for projects related to battery materials where construction has significantly progressed and expected to start during FY27. Neogen Ionics Limited has also started one of the earliest LIB electrolyte facility at Dahej SEZ site in April 2024. For further information, please contact: Nishid Solanki Gopikrishnan Sarathy CDR India Neogen Chemicals Ltd. Tel: +91 98203 68989 Email: investor@neogenchem.com Email: nishid@cdr-india.com 31